(The interview was by email. All the questions were submitted at the same time. That's why it looks weird.) In any case, the current trial is also Anavex 2-73 and donepezil, but taken as separate pills.
Your comments are as useful as your name. I hope people sell based on your post, so I can buy in cheaper. The United States (and the rest of the world) has a patent system based on filing date. If Anavex is the first to file, it will get the patent.
At this time, "the only way to definitively tell if someone has Alzheimer's is through autopsy". I suppose if you are over 65 and you forgot your car keys one time too many, time to pop those pills...?
Adblock plus my greasemonkey/tampermonkey addon, perhaps.
It did appreciate quite a lot in the run-up to results. That said, I see two way the results could have been better: (1) 12/12 patient improvement, and/or (2) full recovery of all 12 patients after 1 month...
Maybe, but I don't know the point of speculating about P3. If P2 full results are fantastic, this will be an immediate buyout candidate, although likely it would be a partnership deal to allow the CEO to collect more shares.
"In the meantime, do not commit any crimes for money to invest."
I guess that rules out working at Goldman Sachs. :-(